Clinical Trial Update: Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding cetuximab to chemotherapy for advanced or recurrent cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN